A meta-analysis on the prevalence of depression in perimenopausal and postmenopausal women in India

Yadav, Vikas; Jain, Akanksha; Dabar, Deepti; Goel, Akhil Dhanesh; Sood, Akanksha; Joshi, Ankur; Agarwal, Sanjay; Nandeshwar, Sunil

doi:10.1016/j.ajp.2021.102581

Cited by 22 publications

(14 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The highest rate of depression among perimenopausal women was 25.99% in Shanghai, China ( 5 ). Relevant studies are still being performed ( 6 ). Besides, managing the risk factors of PMD remains a hotspot for improving the health of perimenopausal women ( 39 , 40 ).…”

Section: Discussionmentioning

confidence: 99%

“…Meta-analysis is being used in research on perimenopausal women and has made important discoveries. For instance, Yadav et al found that depression prevalence in perimenopausal and postmenopausal women in India is 42.47% ( 6 ). By meta-analysis, long-term hormone therapy for perimenopausal and postmenopausal women is also vital for evaluating the effectiveness and safety of treatment methods ( 51 ).…”

Section: Discussionmentioning

confidence: 99%

“…Within the female life cycle, women demonstrate a higher prevalence of or are at risk of depressive symptoms (2)(3)(4). Published research indicates that the highest rate of depression in perimenopause was 25.99% in Shanghai, China (5), and the prevalence of depression in perimenopausal and postmenopausal women in India is 42.47% (6). Furthermore, perimenopausal depression (PMD) is one of the forms of reproductive depression in women related to hormonal changes (7,8).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

et al. 2022

View full text Add to dashboard Cite

BackgroundPerimenopausal depression (PMD) is characterized by affective symptoms as well as menopause-specific somatic complaints and has attracted increasing attention over the past few decades. Using a bibliometric tool, this study aims to evaluate the origin, current hotspots, and research trends on PMD.MethodsArticles with research on PMD were retrieved from Web of Science Core Collection (WoSCC). We used the bibliometric method to analyze publication years, journals, countries, institutions, authors, research hotspots, and trends. We plotted the reference co-citation network and used keywords to analyze the research hotspots and trends.ResultsA total of 209 publications related to PMD were identified from WoSCC on May 8, 2022. The number of publications concerning PMD every year shows an upward trend. Further analysis indicated that 209 articles were contributed by 45 countries, 288 institutions, and 501 authors. The United States contributed the most significant number of publications, followed by China. Harvard University is the core institution of PMD research, and Cohen’s work has had an important impact on another research. The occurrence and pathological mechanisms of depression during the menopausal transition from the knowledge base of PMD. All of them belong to the category of gynecology and psychosis, which reflects the focus of the research topics. Major depression, postmenopausal women, symptoms like hot flashes, and prevalence and risk factors are research hotspots in the PMD field. The frontiers in PMD field that will impact future research are anxiety, meta-analysis, association, and Beck Depression Inventory-II (BDI-II).ConclusionThese findings provide us with the core countries, institutions, and authors in PMD research and point out the direction of attention in this field. The current research focuses on depression, postmenopausal women, hot flashes, and other symptoms, as well as the prevalence and risk factors. The frontiers will be anxiety, meta-analysis, related factors, and depression assessment in future research.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

et al. 2022

View full text Add to dashboard Cite

show abstract

“…There is a substantial prevalence of depression, of about 42.47% of perimenopausal and postmenopausal women in India. [ 12 ] Furthermore, in the United States, about 20% of women experience depression during their postmenopausal period. [ 13 ]…”

Section: Discussionmentioning

confidence: 99%

Improvement in Quality of Life of Postmenopausal Women with Depression with commonly used Antidepressants (Escitalopram vs. Desvenlafaxine)

Mahajan¹,

Arora²,

Tandon³

et al. 2022

Journal of Mid-Life Health

View full text Add to dashboard Cite

Introduction: The postmenopausal symptoms affect the quality of life (QoL) of women. Depression and anxiety too have been associated with diminished QoL. It is known that antidepressants escitalopram and desvenlafaxine are effective in the treatment of depression and anxiety. However, to the best of our knowledge, their comparative effect on the QoL of postmenopausal women with depression and anxiety has not been studied in the Indian setup. Materials and Methods: The present study was a randomized, intention to treat, open-label trial undertaken in North India's a tertiary care teaching hospital. Postmenopausal women attending the psychiatry outpatient department and newly diagnosed with depression and anxiety were randomized in two groups to receive Tab. Escitalopram 10–20 mg and Tab. Desvenlafaxine 50–100 mg. Their QoL was assessed using the WHOQOL BREF scale at baseline, 3 weeks and 6 weeks. Results: Escitalopram was observed to be statistically better than desvenlafaxine in improving the overall QoL score of the WHOQOL-BREF scale. Individually, escitalopram significantly improved the scores of the physical health domain, psychological and environmental domains except for the social relationship domain. Desvenlafaxine significantly improved scores of all four domains. Conclusion: Escitalopram was observed to be significantly better than desvenlafaxine in improving the overall QoL scores. Both the drugs were well tolerated.

show abstract

“…Research Freeman et al (2008) found a positive correlation indicating that a woman will feel more stressed when experiencing disturbing menopausal symptoms. Symptoms experienced during menopause include vasomotor, psychosomatic, and psychological symptoms (Augoulea et al, 2019;Hazlina et al, 2022;Sood et al, 2019;Yadav et al, 2021). Shringarpure et al (2022) found the results of a study of 145 women in urban and rural areas, most of them experienced psychosomatic symptoms such as physical exhaustion-fatigue, sleep problems, difficulty climbing stairs, hot flushes, and body aches.…”

Section: Introductionmentioning

confidence: 99%

Menopause Depression Management Through Self-Esteem Development

Ghate

Minchekar²,

Airlangga³

2023

TAZKIYA

View full text Add to dashboard Cite

n our culture, it is an established myth that menopausal depression is normal for every woman. However, the fact can differ from this common misconception. Women who suffer from it go through dramatic mental changes. Hence, she should get the same attention as any other medical illness. In this study, the researcher tried to find ways to decrease menopausal depression by fostering her self-esteem. The study aimed to find the correlation between depression and self-esteem during menopause among women. A sample of 30 women was collected by purposive sampling from Kolhapur City. The selfesteem scale developed by Singh and Srivastava and depression scale developed by Thakur and Singh were administered to the sample. After calculating row scores, the correlation was found using the product moment method. A negative and significant correlation was found between depression and selfesteem. So women who have high self-esteem will have a low level of depression, and vice versa if the self-esteem is low, the woman will quickly feel depressed.

show abstract

A meta-analysis on the prevalence of depression in perimenopausal and postmenopausal women in India

Cited by 22 publications

References 48 publications

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

Improvement in Quality of Life of Postmenopausal Women with Depression with commonly used Antidepressants (Escitalopram vs. Desvenlafaxine)

Menopause Depression Management Through Self-Esteem Development

Contact Info

Product

Resources

About